Adverum Biotechnologies Inc
NASDAQ:ADVM
Adverum Biotechnologies Inc
Total Other Income
Adverum Biotechnologies Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adverum Biotechnologies Inc
NASDAQ:ADVM
|
Total Other Income
$6.6m
|
CAGR 3-Years
95%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$3.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
-78%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$158m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$55.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Adverum Biotechnologies Inc's Total Other Income?
Total Other Income
6.6m
USD
Based on the financial report for Mar 31, 2024, Adverum Biotechnologies Inc's Total Other Income amounts to 6.6m USD.
What is Adverum Biotechnologies Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
7%
Over the last year, the Total Other Income growth was 82%. The average annual Total Other Income growth rates for Adverum Biotechnologies Inc have been 95% over the past three years , 7% over the past five years .